Dr. David F. Penson, MD

Dr. Penson practices at Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center.

Dr. Penson's NPI, 1164457867, was assigned on July 11, 2006. Dr. Penson graduated from Boston University School of Medicine in 1991. Dr. Penson holds Tennessee license 45072.

Dr. Penson's primary practice is Vanderbilt University Medical Center, at 1211 Medical Center Drive, Nashville, TN 37232 in Davidson County. The practice phone is (615) 322-3454.

Dr. Penson's primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Dr. Penson to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Penson practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Penson's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Penson's licenses on file in 2 states: Tennessee and California.

CMS data shows 690 Medicare services from Dr. Penson across 12 procedure codes in 2024, for 176 Medicare patients. Medicare paid $50,868 for them. Every service was in an office.

CMS counts 176 Medicare patients who saw Dr. Penson in 2024. The largest group is 65 to 74, with 100 patients. 75% of them have cancer, and 73% have high blood pressure. Their average risk score is 1.00, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Penson's median patient age at 72, with 9% women.

In 2024, Dr. Penson wrote 229 Medicare Part D claims for 55 patients. 50% of them were for generic drugs. CMS names the drug for 204 of them, across 6 drugs with 11 or more claims each, at $1,150,040 in total drug cost. In 2023, CMS named 189 claims across 5 drugs.

Dr. Penson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Penson as offering telehealth. CMS counts 14 procedures of prostate resection by Dr. Penson, more than 69% of the clinicians it reports for that procedure.

Dmand AI links 36 papers to Dr. Penson, published from 2011 to 2025. 2022 was the busiest year, with 9. The most frequent topics are Prostatic Neoplasms, Androgen Antagonists and Androgens. Dr. Penson has published most often in Prostate Cancer Prostatic Dis. Dr. Penson's most frequent co-authors are Daniel A. Barocas, MD, Michael Goodman, MD and Karen Elizabeth Hoffman, MD.

Dmand AI links Dr. Penson to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Prostatic Neoplasms and Prostatic Diseases. Open Payments lists research payments to Dr. Penson that name 1 trial.

CMS Open Payments shows 68 general payments to Dr. Penson from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 88% of the total. Pfizer Inc. paid the most, $24,339. It also lists 78 research payments totaling $37,057 from 2016 to 2023, naming 1 clinical trial.

Dr. Penson graduated from Boston University School of Medicine in 1991.